by Michele Chabin |
Jerusalem — Prime Minister Benjamin Netanyahu said on Monday that Israel has no choice but to adhere to the Oslo peace accord, despite the fact that he considers it a “flawed deal.” Speaking to a group of journalists representing Jewish newspapers, Netanyahu said that Israel is committed to carrying out a second redeployment under the treaty’s interim stage. To do otherwise, he said, could jeopardize the country’s international treaties with other nations.
by Michele Chabin |
Jerusalem — Eli Sanders, an incoming senior at Columbia University, never gave much thought to campus anti-Semitism — that is, until a fellow student submitted a controversial article to the Columbia Daily Spectator.
“It was an opinion piece, and it said that the hands of the Jews are stained in blood,” Sanders, the paper’s chief editor, recalls during a tour of the Yad Vashem Holocaust Memorial in Jerusalem.
Followers of Islam who kill civilians in the name of their faith, as the bombers of the U.S. embassies in Africa are suspected of doing, distort the literal words and interpreted meaning of the Koran, experts on Islam say.
The experts contacted by The Jewish Week, both Jewish and Muslim, point to the Koranic verse, “If you take an individual’s life, it is as if you have killed humanity.” The verse is similar to one in the Talmud.
James Besser |
Washington — Ehud Barak, the general-turned-politician who hopes to lead Israel’s Labor Party out of the wilderness, tried out some of the themes that will drive his campaign for the post of prime minister this week during his first high-profile visit to the capital.
The battered peace process and Barak’s view that the government of Prime Minister Benjamin Netanyahu is damaging Israel’s security by allowing it to languish were at the top of his agenda.
Seeing an area of unrealized potential, Israeli firms and trade officials are preparing a major push in marketing biotechnology partnerships with American companies. “Israel has tremendous potential in life sciences,” said David Rubin, Israel’s trade envoy to North America at a recent Manhattan conference exploring cooperative ventures. “We have the scientists and the means to do the work. In the next five to 10 years, we can capture a larger share of the international market.”